Quick Answer
CITIUS ONCOLOGY, INC. reported Total Assets of $100.94 million for the year ending 2025.
- CITIUS ONCOLOGY, INC. showed an increase of +19.6% in Total Assets from 2024 to 2025.
- This data is from CITIUS ONCOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on December 23, 2025.
- XBRL data for this metric is available from 2021 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $256.7 thousand | Q1 2023: $68.82 million | Q2 2023: $69.85 million | Q4 2023: $72.62 million | Q1 2024: $48.68 million | Q2 2024: $49.19 million | Q4 2024: $90.48 million | Q1 2025: $91.44 million | Q2 2025: $91.71 million | Q3 2025: $100.94 million | Q4 2025: $109.97 million.
- Over the full 6 years of available data (2021 to 2025), CITIUS ONCOLOGY, INC.'s Total Assets has grown by 79,746.0%.
- Historical annual values: Fiscal year 2025: $100.94 million | Fiscal year 2024: $84.37 million | Fiscal year 2023: $72.62 million | Fiscal year 2023: $47.73 million | Fiscal year 2022: $68.19 million | Fiscal year 2021: $126.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: